SSA
GMED icon

Schonfeld Strategic Advisors’s Globus Medical GMED Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,240
Closed -$987K – 2241
2025
Q3 		$987K Buy
17,240
+2,357
+16% +$136K 0.01% 1375
2025
Q2 		$878K Buy
+14,883
New +$962K 0.01% 1344
2025
Q1 		– Sell
-21,470
Closed -$1.78M – 2307
2024
Q4 		$1.78M Buy
21,470
+16,989
+379% +$1.34M 0.01% 883
2024
Q3 		$321K Buy
+4,481
New +$316K ﹤0.01% 1626
2024
Q2 		– Sell
-16,883
Closed -$906K – 2310
2024
Q1 		$906K Sell
16,883
-7,411
-31% -$398K 0.01% 1267
2023
Q4 		$1.29M Buy
24,294
+11,566
+91% +$564K 0.01% 945
2023
Q3 		$632K Sell
12,728
-41,697
-77% -$2.33M ﹤0.01% 1148
2023
Q2 		$3.24M Buy
+54,425
New +$3.1M 0.03% 612
2023
Q1 		– Sell
-21,151
Closed -$1.57M – 2289
2022
Q4 		$1.57M Buy
21,151
+4,951
+31% +$337K 0.01% 926
2022
Q3 		$966K Sell
16,200
-48,127
-75% -$2.9M 0.01% 1291
2022
Q2 		$3.61M Sell
64,327
-95,346
-60% -$6.27M 0.04% 560
2022
Q1 		$11.8M Sell
159,673
-23,984
-13% -$1.67M 0.11% 234
2021
Q4 		$13.3M Buy
+183,657
New +$13.3M 0.12% 226
2021
Q3 		– Sell
-3,272
Closed -$254K – 2264
2021
Q2 		$254K Buy
+3,272
New +$233K ﹤0.01% 1549
2020
Q4 		– Sell
-14,709
Closed -$728K – 1675
2020
Q3 		$728K Sell
14,709
-3,742
-20% -$193K 0.01% 800
2020
Q2 		$880K Buy
+18,451
New +$890K 0.02% 636
2020
Q1 		– Sell
-5,805
Closed -$342K – 1278
2019
Q4 		$342K Buy
+5,805
New +$315K 0.01% 908
2018
Q4 		– Sell
-31,700
Closed -$1.8M – 1128
2018
Q3 		$1.8M Sell
31,700
-47,878
-60% -$2.52M 0.08% 308
2018
Q2 		$4.01M Buy
79,578
+39,960
+101% +$2.08M 0.22% 160
2018
Q1 		$1.97M Buy
+39,618
New +$1.86M 0.15% 204
2017
Q2 		– Sell
-8,795
Closed -$261K – 669
2017
Q1 		$261K Buy
+8,795
New +$240K 0.03% 496

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Schonfeld Strategic Advisors's GMED Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 17,240 shares — an estimated $987K sold.

Schonfeld Strategic Advisors first reported a position in GMED in Q1 2017 and held it in 21 quarters. The position peaked at $13.3M in Q4 2021. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Schonfeld Strategic Advisors reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 17,240 Globus Medical shares in Q4 2025, an estimated $987K.
  • Schonfeld Strategic Advisors first reported a position in Globus Medical in Q1 2017 and held it in 21 quarters.
  • Schonfeld Strategic Advisors's Globus Medical position peaked at $13.3M in Q4 2021.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.